EGFR and non-small cell lung carcinoma: Treatment-naïve patient selection for EGFR mutation assessment on cfDNA should take into account the same criteria as for tumor tissue: advanced stage or metastatic nonsquamous NSCLC, squamous NSCLC in younger patients and/or never smokers.